Severe scalp hair loss in a female patient with acromegaly treated with lanreotide autogel after unsuccessful surgery

Scalp hair loss is an underreported adverse event of somatostatin analogs therapy that in severe cases may require treatment withdrawal. It can be related to an acute decrease in GH/IGF-1 levels, but a direct effect cannot be ruled out.

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Case Rep
Main Authors: Alvarez-Escola, Cristina, Cárdenas-Salas, Jersy J, Pelegrina, Beatriz, Sanz-Valtierra, Angel, Lecumberri, Beatriz
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2015
Assuntos:
Case Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4641480/
https://ncbi.nlm.nih.gov/pubmed/26576278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.388
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados